Inventor · disambiguated record
Stefan Kaulfuss
Also filed as: KAULFUSS STEFAN
13 granted patents·10 pending applications·40 citations·filing 2013–2023
89Inventor score
Files withBAYER AG12BROAD INST INC5Bayer Pharma AG5DEUTSCHES KREBSFORSCHUNGSZENTRUM DKFZ STIFTUNG DES OEFFENTLICHEN RECHTS1
Top patents by PatentIndex Score
23 records- 0190US11891404B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2022·Granted Feb 6, 2024·1 cites·10 claims
- 0288US12152041B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2022·Granted Nov 26, 2024·1 cites·6 claims
- 0388US9957235B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted May 1, 2018·8 cites·34 claims
- 0487US11440923B2Substituted macrocyclic indole derivativesBAYER AG·Filed 2018·Granted Sep 13, 2022·3 cites·15 claims
- 0586US11478451B1Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Oct 25, 2022·3 cites·16 claims
- 0686US11401278B2Macrocyclic indole derivativesBROAD INST INC·Filed 2018·Granted Aug 2, 2022·3 cites·13 claims
- 0786US9951027B2Benzimidazol-2-amines as MIDH1 inhibitorsBayer Pharma AG·Filed 2015·Granted Apr 24, 2018·8 cites·22 claims
- 0885US11447504B2Macrocyclic chlorine substituted indole derivativesBAYER AG·Filed 2018·Granted Sep 20, 2022·3 cites·14 claims
- 0985US11286263B2Macrocyclic fluorine substituted indole derivativesBROAD INST INC·Filed 2018·Granted Mar 29, 2022·3 cites·9 claims
- 1079US10137110B21-cyclohexyl-2-phenylaminobenzimidazoles as mIDH1 inhibitors for the treatment of tumorsBayer Pharma AG·Filed 2015·Granted Nov 27, 2018·4 cites·29 claims
- 1174US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 1271US9708311B2Benzimidazole derivatives as EP4 antagonistsBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·2 cites·10 claims
- 1364US2023405015A1Substituted 3,6-dihydro-2h-1,3,4-oxadiazin-2-ones for the treatment of sarcomaBAYER AG·Filed 2023·Application pending·0 cites
- 1462US2024109850A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1562US2024150277A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1654US2025188075A1Substituted heterocyclic csnk1 inhibitorsBROAD INST INC·Filed 2023·Application pending·0 cites
- 1751US10442772B2Benzimidazol-2-amines as mIDH1 inhibitorsBayer Pharma AG·Filed 2018·Granted Oct 15, 2019·0 cites·21 claims
- 1849US2023365554A1Substituted pyrrolo-pyridinone derivatives and therapeutic uses thereofBROAD INST INC·Filed 2021·Application pending·0 cites
- 1948US2023322767A1Aryl substituted pyrrolo-pyridinones and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2048US2022411381A1Pyrimidinedione derivativesBAYER AG·Filed 2020·Application pending·0 cites
- 2147US2023391769A1Substituted heterocyclic compounds and therapeutic uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2243US2021253598A1Aryl annulated macrocyclic indole derivativesBAYER AG·Filed 2018·Application pending·0 cites
- 2336US2021113598A1Combination of MIDH1 Inhibitors and DNA Hypomethylating Agents (HMA)DEUTSCHES KREBSFORSCHUNGSZENTRUM DKFZ STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Kaulfuss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →